The pharmaceutical industry in the United States is experiencing a rapid surge in requirement for Tirzepatide APIs. This powerful medication, used to treat insulin resistance, has gained considerable attention from both individuals and medical practitioners. As a result, numerous manufacturers have emerged as producers of Tirzepatide APIs in the US